home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,044 rows where docket_id = "FDA-2007-D-0369" and posted_year = 2024 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 2

  • Other 1,038
  • Notice 6

posted_year 1

  • 2024 · 1,044 ✖

agency_id 1

  • FDA 1,044
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-D-0369-2066 FDA None FDA-2007-D-0369 PSG_216993 - Draft Guidance on Quizartinib Dihydrochloride Other Guidance 2024-11-21T05:00:00Z 2024 11 2024-11-21T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:34:51Z   1 0 09000064868293cc
FDA-2007-D-0369-2018 FDA None FDA-2007-D-0369 PSG_020833 - Draft Guidance on Fluticasone Propionate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2025-01-17T02:01:11Z   1 0 0900006486829349
FDA-2007-D-0369-2060 FDA None FDA-2007-D-0369 PSG_216632 - Draft Guidance on Adapalene; Benzoyl Peroxide; Clindamycin Phosphate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-12-11T02:01:02Z   1 0 09000064868293ca
FDA-2007-D-0369-2012 FDA None FDA-2007-D-0369 PSG_017533-Sus - Draft Guidance on Clonazepam Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T19:55:15Z   1 0 0900006486829330
FDA-2007-D-0369-2013 FDA None FDA-2007-D-0369 PSG_018687 - Draft Guidance on Labetalol Hydrochloride Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T19:59:07Z   1 0 0900006486829332
FDA-2007-D-0369-2021 FDA None FDA-2007-D-0369 PSG_021190 - Draft Guidance on Buspirone Hydrochloride Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:08:24Z   1 0 0900006486829350
FDA-2007-D-0369-2022 FDA None FDA-2007-D-0369 PSG_021359 - Draft Guidance on Nitroglycerin Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:08:59Z   1 0 0900006486829357
FDA-2007-D-0369-2057 FDA None FDA-2007-D-0369 PSG_215830 - Draft Guidance on Ritlecitinib Tosylate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:28:25Z   1 0 09000064868293c3
FDA-2007-D-0369-2053 FDA None FDA-2007-D-0369 PSG_215179 - Draft Guidance on Pemetrexed Disodium Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:26:20Z   1 0 09000064868293b4
FDA-2007-D-0369-2015 FDA None FDA-2007-D-0369 PSG_020281 - Draft Guidance on Tramadol Hydrochloride Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T20:00:27Z   1 0 0900006486829336
FDA-2007-D-0369-2007 FDA None FDA-2007-D-0369 PSG_009170 - Draft Guidance on Primidone Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T19:52:32Z   1 0 0900006486829323
FDA-2007-D-0369-2006 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z   2024-11-21T19:50:01Z 2024-27048 0 0 0900006486829e19
FDA-2007-D-0369-2027 FDA None FDA-2007-D-0369 PSG_021641 - Draft Guidance on Rasagiline Mesylate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:11:57Z   1 0 0900006486829361
FDA-2007-D-0369-2026 FDA None FDA-2007-D-0369 PSG_021487-ODT - Draft Guidance on Memantine Hydrochloride Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:11:26Z   1 0 090000648682935f
FDA-2007-D-0369-2038 FDA None FDA-2007-D-0369 PSG_087954 - Draft Guidance on Phytonadione Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:18:05Z   1 0 0900006486829381
FDA-2007-D-0369-2040 FDA None FDA-2007-D-0369 PSG_203491 - Draft Guidance on Nepafenac Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:19:09Z   1 0 0900006486829385
FDA-2007-D-0369-2056 FDA None FDA-2007-D-0369 PSG_215559 - Draft Guidance on Palovarotene Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:27:51Z   1 0 09000064868293c1
FDA-2007-D-0369-2051 FDA None FDA-2007-D-0369 PSG_213674 - Draft Guidance on Enzalutamide Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:25:08Z   1 0 09000064868293a6
FDA-2007-D-0369-2064 FDA None FDA-2007-D-0369 PSG_217469 - Draft Guidance on Cyclosporine Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:33:49Z   1 0 09000064868293de
FDA-2007-D-0369-2050 FDA None FDA-2007-D-0369 PSG_213586 - Draft Guidance on Risperidone Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:24:37Z   1 0 09000064868293a4
FDA-2007-D-0369-2010 FDA None FDA-2007-D-0369 PSG_016084 - Draft Guidance on Allopurinol Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T19:54:11Z   1 0 0900006486829329
FDA-2007-D-0369-2020 FDA None FDA-2007-D-0369 PSG_021184-Cre-0.05P - Draft Guidance on Tazarotene Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:07:46Z   1 0 090000648682934e
FDA-2007-D-0369-2024 FDA None FDA-2007-D-0369 PSG_021470 - Draft Guidance on Azelaic Acid Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:10:13Z   1 0 090000648682935b
FDA-2007-D-0369-2033 FDA None FDA-2007-D-0369 PSG_022341 - Draft Guidance on Liraglutide Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:15:06Z   1 0 0900006486829376
FDA-2007-D-0369-2014 FDA None FDA-2007-D-0369 PSG_020216 - Draft Guidance on Estrogens, Conjugated Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2025-09-15T09:00:17Z   1 0 0900006486829334
FDA-2007-D-0369-2048 FDA None FDA-2007-D-0369 PSG_211728 - Draft Guidance on Mitomycin Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2025-03-06T02:00:19Z   1 0 09000064868293a0
FDA-2007-D-0369-2042 FDA None FDA-2007-D-0369 PSG_205641 - Draft Guidance on Mometasone Furoate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2025-01-17T02:01:11Z   1 0 0900006486829389
FDA-2007-D-0369-2016 FDA None FDA-2007-D-0369 PSG_020692 - Draft Guidance on Salmeterol Xinafoate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2025-01-17T02:01:10Z   1 0 0900006486829345
FDA-2007-D-0369-2023 FDA None FDA-2007-D-0369 PSG_021395 - Draft Guidance on Tiotropium Bromide Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2025-01-17T02:00:59Z   1 0 0900006486829359
FDA-2007-D-0369-2049 FDA None FDA-2007-D-0369 PSG_212905 - Draft Guidance on Cantharidin Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:24:04Z   1 0 09000064868293a2
FDA-2007-D-0369-2058 FDA None FDA-2007-D-0369 PSG_216338 - Draft Guidance on Paclitaxel Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:28:54Z   1 0 09000064868293c5
FDA-2007-D-0369-2039 FDA None FDA-2007-D-0369 PSG_203159 - Draft Guidance on Levonorgestrel Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:18:39Z   1 0 0900006486829383
FDA-2007-D-0369-2046 FDA None FDA-2007-D-0369 PSG_210251 - Draft Guidance on Bictegravir Sodium; Emtricitabine; Tenofovir Alafenamide Fumarate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:22:28Z   1 0 090000648682939c
FDA-2007-D-0369-2059 FDA None FDA-2007-D-0369 PSG_216387 - Draft Guidance on Acalabrutinib Maleate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:29:28Z   1 0 09000064868293c7
FDA-2007-D-0369-2035 FDA None FDA-2007-D-0369 PSG_050065 - Draft Guidance on Dexamethasone; Neomycin Sulfate; Polymyxin B Sulfate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:16:09Z   1 0 090000648682937a
FDA-2007-D-0369-2061 FDA None FDA-2007-D-0369 PSG_217006 - Draft Guidance on Aripiprazole Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:32:15Z   1 0 09000064868293ce
FDA-2007-D-0369-2063 FDA None FDA-2007-D-0369 PSG_217388 - Draft Guidance on Eplontersen Sodium Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:33:17Z   1 0 09000064868293d2
FDA-2007-D-0369-2025 FDA None FDA-2007-D-0369 PSG_021481 - Draft Guidance on Enfuvirtide Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:10:50Z   1 0 090000648682935d
FDA-2007-D-0369-2041 FDA None FDA-2007-D-0369 PSG_203565 - Draft Guidance on Ferric Carboxymaltose Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2025-06-05T09:00:09Z   1 0 0900006486829387
FDA-2007-D-0369-2055 FDA None FDA-2007-D-0369 PSG_215344 - Draft Guidance on Magnesium Sulfate; Polyethylene Glycol 3350; Potassium Chloride; Sodium Chloride; Sodium Sulfate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:27:21Z   1 0 09000064868293bf
FDA-2007-D-0369-2036 FDA None FDA-2007-D-0369 PSG_050777 - Draft Guidance on Tacrolimus Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:16:54Z   1 0 090000648682937c
FDA-2007-D-0369-2037 FDA None FDA-2007-D-0369 PSG_083722 - Draft Guidance on Phytonadione Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:17:26Z   1 0 090000648682937e
FDA-2007-D-0369-2054 FDA None FDA-2007-D-0369 PSG_215309 - Draft Guidance on Ruxolitinib Phosphate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:26:49Z   1 0 09000064868293b6
FDA-2007-D-0369-2009 FDA None FDA-2007-D-0369 PSG_011745 - Draft Guidance on Phytonadione Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T19:53:37Z   1 0 0900006486829327
FDA-2007-D-0369-2011 FDA None FDA-2007-D-0369 PSG_016084-Sus - Draft Guidance on Allopurinol Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T19:54:42Z   1 0 090000648682932e
FDA-2007-D-0369-2028 FDA None FDA-2007-D-0369 PSG_021862 - Draft Guidance on Nepafenac Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:12:29Z   1 0 0900006486829363
FDA-2007-D-0369-2065 FDA None FDA-2007-D-0369 PSG_218490 - Draft Guidance on Macitentan; Tadalafil Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:34:21Z   1 0 09000064868293e0
FDA-2007-D-0369-2044 FDA None FDA-2007-D-0369 PSG_208558 - Draft Guidance on Olaparib Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:21:24Z   1 0 0900006486829398
FDA-2007-D-0369-2034 FDA None FDA-2007-D-0369 PSG_022518 - Draft Guidance on Formoterol Fumarate; Mometasone Furoate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2025-01-17T02:01:10Z   1 0 0900006486829378
FDA-2007-D-0369-2031 FDA None FDA-2007-D-0369 PSG_022150 - Draft Guidance on Icatibant Acetate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:14:05Z   1 0 0900006486829367
FDA-2007-D-0369-2032 FDA None FDA-2007-D-0369 PSG_022180 - Draft Guidance on Ferumoxytol Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:14:36Z   1 0 0900006486829369
FDA-2007-D-0369-2030 FDA None FDA-2007-D-0369 PSG_020386 - Draft Guidance on Losartan Potassium Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:13:34Z   1 0 0900006486829343
FDA-2007-D-0369-2047 FDA None FDA-2007-D-0369 PSG_211413 - Draft Guidance on Cefazolin Sodium Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:23:01Z   1 0 090000648682939e
FDA-2007-D-0369-2043 FDA None FDA-2007-D-0369 PSG_206947 - Draft Guidance on Lenvatinib Mesylate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:20:49Z   1 0 0900006486829396
FDA-2007-D-0369-2008 FDA None FDA-2007-D-0369 PSG_010104 - Draft Guidance on Phytonadione Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T19:53:05Z   1 0 0900006486829325
FDA-2007-D-0369-2062 FDA None FDA-2007-D-0369 PSG_217064 - Draft Guidance on Phentolamine Mesylate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2024-11-21T21:32:46Z   1 0 09000064868293d0
FDA-2007-D-0369-2017 FDA None FDA-2007-D-0369 PSG_020831 - Draft Guidance on Formoterol Fumarate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2025-01-17T02:01:07Z   1 0 0900006486829347
FDA-2007-D-0369-2019 FDA None FDA-2007-D-0369 PSG_021077 - Draft Guidance on Fluticasone Propionate; Salmeterol Xinafoate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2025-01-17T02:01:14Z   1 0 090000648682934b
FDA-2007-D-0369-2029 FDA None FDA-2007-D-0369 PSG_021929 - Draft Guidance on Budesonide; Formoterol Fumarate Dihydrate Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2025-01-17T02:01:10Z   1 0 0900006486829365
FDA-2007-D-0369-2052 FDA None FDA-2007-D-0369 PSG_214324 - Draft Guidance on Treprostinil Other Guidance 2024-11-20T05:00:00Z 2024 11 2024-11-20T05:00:00Z 2025-01-22T04:59:59Z 2025-01-17T02:01:14Z   1 0 09000064868293a8
FDA-2007-D-0369-2045 FDA None FDA-2007-D-0369 PSG_209830 - Draft Guidance on Aripiprazole Lauroxil Other Guidance 2024-11-20T00:00:00Z 2024 11 2024-11-20T00:00:00Z 2025-01-22T04:59:59Z 2025-05-09T01:17:15Z   1 0 090000648682939a
FDA-2007-D-0369-2004 FDA None FDA-2007-D-0369 PSG_078690 - Draft Guidance on Carbidopa; Levodopa Other Guidance 2024-11-14T05:00:00Z 2024 11 2024-11-14T05:00:00Z 2024-12-31T04:59:59Z 2024-11-14T21:10:46Z   1 0 090000648681414e
FDA-2007-D-0369-2003 FDA None FDA-2007-D-0369 PSG_011808 - Draft Guidance on Thioridazine Hydrochloride Other Guidance 2024-11-14T05:00:00Z 2024 11 2024-11-14T05:00:00Z 2024-12-31T04:59:59Z 2024-11-14T21:10:38Z   1 0 09000064867f21ca
FDA-2007-D-0369-1995 FDA None FDA-2007-D-0369 PSG_209899 - Draft Guidance on Ozanimod Hydrochloride Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T20:56:51Z   1 0 09000064867f2d7d
FDA-2007-D-0369-1954 FDA None FDA-2007-D-0369 PSG_050759 - Draft Guidance on Mycophenolate Mofetil Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T12:54:37Z   1 0 09000064867f240b
FDA-2007-D-0369-1972 FDA None FDA-2007-D-0369 PSG_083976 - Draft Guidance on Methyltestosterone Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T12:54:47Z   1 0 09000064867f242f
FDA-2007-D-0369-1981 FDA None FDA-2007-D-0369 PSG_200175 - Draft Guidance on Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T12:54:53Z   1 0 09000064867f2441
FDA-2007-D-0369-1983 FDA None FDA-2007-D-0369 PSG_201280 - Draft Guidance on Linagliptin Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T12:54:54Z   1 0 09000064867f2445
FDA-2007-D-0369-1953 FDA None FDA-2007-D-0369 PSG_050725 - Draft Guidance on Amoxicillin; Clavulanate Potassium Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T12:54:36Z   1 0 09000064867f2409
FDA-2007-D-0369-1986 FDA None FDA-2007-D-0369 PSG_201373 - Draft Guidance on Fexofenadine Hydrochloride Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T12:54:56Z   1 0 09000064867f244b
FDA-2007-D-0369-1957 FDA None FDA-2007-D-0369 PSG_050722 - Draft Guidance on Mycophenolate Mofetil Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T12:54:38Z   1 0 09000064867f2411
FDA-2007-D-0369-1975 FDA None FDA-2007-D-0369 PSG_200534 - Draft Guidance on Oxycodone Hydrochloride Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T12:54:49Z   1 0 09000064867f2435
FDA-2007-D-0369-1889 FDA None FDA-2007-D-0369 PSG_022344 - Draft Guidance on Lamivudine; Tenofovir Disoproxil Fumara Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:44:53Z   1 0 09000064867f237f
FDA-2007-D-0369-1941 FDA None FDA-2007-D-0369 PSG_050542 - Draft Guidance on Amoxicillin Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:11Z   1 0 09000064867f23f1
FDA-2007-D-0369-1938 FDA None FDA-2007-D-0369 PSG_050662 - Draft Guidance on Clarithromycin Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:10Z   1 0 09000064867f23eb
FDA-2007-D-0369-1893 FDA None FDA-2007-D-0369 PSG_022363 - Draft Guidance on Pitavastatin Calcium Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:44:57Z   1 0 09000064867f2391
FDA-2007-D-0369-1936 FDA None FDA-2007-D-0369 PSG_050641-Cap-150MG - Draft Guidance on Doxycycline Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:08Z   1 0 09000064867f23e7
FDA-2007-D-0369-1797 FDA None FDA-2007-D-0369 PSG_019915 - Draft Guidance on Fosinopril Sodium Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:25Z   1 0 09000064867ee4fa
FDA-2007-D-0369-1817 FDA None FDA-2007-D-0369 PSG_020251 - Draft Guidance on Ranitidine Hydrochloride Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:29Z   1 0 09000064867f2123
FDA-2007-D-0369-1822 FDA None FDA-2007-D-0369 PSG_020180 - Draft Guidance on Finasteride Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:32Z   1 0 09000064867f212d
FDA-2007-D-0369-1832 FDA None FDA-2007-D-0369 PSG_020264 - Draft Guidance on Megestrol Acetate Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:33Z   1 0 09000064867f2141
FDA-2007-D-0369-1836 FDA None FDA-2007-D-0369 PSG_020286 - Draft Guidance on Fosinopril Sodium; Hydrochlorothiazide Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:35Z   1 0 09000064867f2149
FDA-2007-D-0369-1839 FDA None FDA-2007-D-0369 PSG_020297 - Draft Guidance on Carvedilol Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:35Z   1 0 09000064867f214f
FDA-2007-D-0369-1843 FDA None FDA-2007-D-0369 PSG_020397 - Draft Guidance on Tizanidine Hydrochloride Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:36Z   1 0 09000064867f2157
FDA-2007-D-0369-1858 FDA None FDA-2007-D-0369 PSG_020528 - Draft Guidance on Trandolapril Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:39Z   1 0 09000064867f2175
FDA-2007-D-0369-1871 FDA None FDA-2007-D-0369 PSG_020702 - Draft Guidance on Atorvastatin Calcium Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:42Z   1 0 09000064867f2190
FDA-2007-D-0369-1876 FDA None FDA-2007-D-0369 PSG_020713 - Draft Guidance on Desogestrel; Ethinyl Estradiol Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:45Z   1 0 09000064867f219a
FDA-2007-D-0369-1877 FDA None FDA-2007-D-0369 PSG_020717 - Draft Guidance on Modafinil Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:45Z   1 0 09000064867f219c
FDA-2007-D-0369-1879 FDA None FDA-2007-D-0369 PSG_020658 - Draft Guidance on Ropinirole Hydrochloride Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:45Z   1 0 09000064867f21a0
FDA-2007-D-0369-1882 FDA None FDA-2007-D-0369 PSG_020636 - Draft Guidance on Nevirapine Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:46Z   1 0 09000064867f21b0
FDA-2007-D-0369-1884 FDA None FDA-2007-D-0369 PSG_020704 - Draft Guidance on Loratadine Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T22:45:46Z   1 0 09000064867f21b4
FDA-2007-D-0369-1944 FDA None FDA-2007-D-0369 PSG_050665 - Draft Guidance on Cefprozil Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-14T13:15:12Z   1 0 09000064867f23f7
FDA-2007-D-0369-1991 FDA None FDA-2007-D-0369 PSG_009838 - Draft Guidance on Reserpine Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-13T16:42:38Z   1 0 09000064867ee375
FDA-2007-D-0369-1802 FDA None FDA-2007-D-0369 PSG_019906 - Draft Guidance on Clomipramine Hydrochloride Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-13T19:22:23Z   1 0 09000064867f2105
FDA-2007-D-0369-1840 FDA None FDA-2007-D-0369 PSG_020448 - Draft Guidance on Loperamide Hydrochloride Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-13T19:29:13Z   1 0 09000064867f2151
FDA-2007-D-0369-1883 FDA None FDA-2007-D-0369 PSG_020667 - Draft Guidance on Pramipexole Dihydrochloride Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-13T19:42:00Z   1 0 09000064867f21b2
FDA-2007-D-0369-1897 FDA None FDA-2007-D-0369 PSG_022565 - Draft Guidance on Ibuprofen; Phenylephrine Hydrochloride Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2025-11-17T10:00:09Z   1 0 09000064867f2399
FDA-2007-D-0369-1965 FDA None FDA-2007-D-0369 PSG_083266 - Draft Guidance on Estrogens, Esterified Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T12:54:43Z   1 0 09000064867f2421
FDA-2007-D-0369-1966 FDA None FDA-2007-D-0369 PSG_050749 - Draft Guidance on Cefdinir Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T12:54:44Z   1 0 09000064867f2423
FDA-2007-D-0369-1950 FDA None FDA-2007-D-0369 PSG_062279 - Draft Guidance on Griseofulvin, Microcrystalline; Griseofulvin, Microsize Other Guidance 2024-11-12T05:00:00Z 2024 11 2024-11-12T05:00:00Z 2024-12-31T04:59:59Z 2024-11-12T12:54:35Z   1 0 09000064867f2403

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 2902.887ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API